Falcigo-SP Kit (Pyrimethamine 25mg + Sulphadoxine 750mg)

What is Falcigo-SP Kit (Pyrimethamine 25mg + Sulphadoxine 750mg)?

Falcigo-SP Kit is a combination antimalarial medication containing Pyrimethamine 25mg and Sulphadoxine 750mg in a fixed-dose tablet. It is indicated for the treatment of uncomplicated malaria caused by Plasmodium falciparum, particularly in areas where chloroquine resistance is prevalent. This kit is designed for single-dose administration under medical supervision, often used in public health programs and emergency treatment settings. It is not suitable for prophylaxis or severe malaria cases.

Key features

• Fixed-Dose Combination — Ensures accurate dosing of both pyrimethamine and sulphadoxine in one tablet.
• Single-Dose Regimen — Simplifies treatment, improving patient compliance in resource-limited settings.
• WHO-Recommended — Included in treatment guidelines for uncomplicated falciparum malaria in specific regions.
• Cost-Effective — Offers an affordable option for malaria treatment in endemic areas.
• Therapeutic Synergy — Dual mechanism inhibits parasite folate synthesis, enhancing efficacy.
• Oral Administration — No injection required, suitable for outpatient use.
• Stable at Room Temperature — Ideal for tropical climates without refrigeration needs.

Who is Falcigo-SP Kit (Pyrimethamine 25mg + Sulphadoxine 750mg) for?

This medication is intended for adults and children weighing over 10 kg diagnosed with uncomplicated Plasmodium falciparum malaria. It is primarily used in endemic regions of Africa and parts of Asia where SP sensitivity remains. It is not recommended for pregnant women in the first trimester or individuals with known hypersensitivity to sulfa drugs. Use should always follow confirmed diagnosis and local resistance patterns.

How does Falcigo-SP Kit (Pyrimethamine 25mg + Sulphadoxine 750mg) compare?

Compared to artemisinin-based combination therapies (ACTs), Falcigo-SP has lower efficacy in many regions due to widespread resistance. However, it remains a viable alternative in areas with confirmed SP sensitivity. Unlike ACTs, it lacks rapid parasite clearance but offers lower cost and simpler storage. It is not interchangeable with antimalarial prophylaxis drugs like doxycycline or mefloquine. Its role is largely restricted to specific treatment protocols rather than broad-use therapy.